Revlimid.com: Information for Patients and Health Care Providers
REVLIMID® (lenalidomide) in combination with dexamethasone is indicated for the treatment of multiple myeloma patients who have received at least one prior therapy.
News
- The H1N1 Swine Flu Vaccine And Multiple Myeloma: A Comprehensive Review
- A New Beacon For The Multiple Myeloma Community
- Red Wine, Resveratrol, And Multiple Myeloma: The Evidence Is Promising, But Needs Further Study
- Swine Flu Vaccinations Recommended For Multiple Myeloma Patients
- Blood Cancers Forum Focuses On Importance Of Clinical Trials
- New Test Helps Predict More Specific Prognoses For Smoldering Myeloma Patients
- Dose-Adjusted Revlimid-Dexamethasone Combination Is Safe And Effective In Multiple Myeloma Patients With Reduced Kidney Function
- Regardless Of Prior Therapies, Velcade Is Superior Over Dexamethasone In Relapsed Multiple Myeloma Patients
- Beacon NewsFlashes – March 9, 2010
- Study Documents The Impact Of Age At Diagnosis On Myeloma Patient Survival
- Red Wine, Resveratrol, And Multiple Myeloma: The Evidence Is Promising, But Needs Further Study
- Swine Flu Vaccinations Recommended For Multiple Myeloma Patients
- Study Shows Higher Survival With Revlimid And Low-Dose Dexamethasone Than Revlimid And High-Dose Dexamethasone In Multiple Myeloma Patients
- A New Beacon For The Multiple Myeloma Community
- Study Supports Use Of Kyphoplasty For Multiple Myeloma Patients
Resources
- Defibrotide
- Personal Perspective: Former Football Star And Young Father “Dominates” Cancer With Optimism, Information, And Support
- Thought Leader Perspective: Dr. Robert Kyle On Myeloma Treatments Requiring Further Study
- Thought Leader Perspective: Dr. Robert Kyle On Treating Multiple Myeloma
- Papayas, Papain and Multiple Myeloma: A Potential Adjunct Therapy That Requires Further Evaluation
- Red Wine, Resveratrol, And Multiple Myeloma: The Evidence Is Promising, But Needs Further Study
- Personal Perspective: Former Football Star And Young Father “Dominates” Cancer With Optimism, Information, And Support
- Pomalidomide (Actimid, CC-4047)
- Kidney Failure In Multiple Myeloma Patients - Part 4: Hemodialysis
- Kidney Failure In Multiple Myeloma Patients - Part 1: Overview
Links
Most Recent Comments
- Julie Shilane: Hi Carol, The following Web site lists all of the clinical trials that are currently being conducted...
- Carol Costner: Thank you for the information on MM. My husband has had a stem cell transplant, in November, 2007, and...
- julie: This blog posting has an interesting discussion about the appropriateness of using the word “cure”...
- Malcolm: It always amuses me to hear that standard line that there is not yet enough research to warrant taking the...
- L: GREAT news!!!
Subscribe
News Archives
- ▼2010 (39)
- ▼ March (7)
- New Test Helps Predict More Specific Prognoses For Smoldering Myeloma Patients
- Dose-Adjusted Revlimid-Dexamethasone Combination Is Safe And Effective In Multiple Myeloma Patients With Reduced Kidney Function
- Regardless Of Prior Therapies, Velcade Is Superior Over Dexamethasone In Relapsed Multiple Myeloma Patients
- Beacon NewsFlashes – March 9, 2010
- Study Documents The Impact Of Age At Diagnosis On Myeloma Patient Survival
- Genetic Risk Factors And Treatment History May Predict Response In Patients With Relapsed/Refractory Myeloma, Study Finds
- International Effort Updates Results From Multiple Myeloma Stem Cell Transplant Trials
- ► February (15)
- Thalidomide As Induction And Maintenance Therapy Improves Response Rates In Multiple Myeloma Patients
- The Top Myeloma Research Of 2009
- Achieving Very Good Partial Response Indicates A Good Prognosis For Multiple Myeloma Patients, Study Finds
- Beacon NewsFlashes – February 18, 2010
- Curcumin And Multiple Myeloma: Preclinical And Early Clinical Studies Are Promising; Still Awaiting More Clinical Evidence
- Total Therapy Regimen May Be Highly Effective In Newly Diagnosed Myeloma Patients
- Unresponsiveness To Revlimid Or Thalidomide Indicates Poor Response To Stem Cell Transplant, Study Finds
- Revlimid Maintenance Therapy Is Added To Multiple Myeloma Treatment Guidelines
- Revlimid-Cyclophosphamide-Prednisone Combination May Be Highly Effective For Refractory Multiple Myeloma Patients
- Vertebroplasty Relieves Pain And Restores Mobility In Myeloma-Related Spinal Fractures, Study Finds
- Bone Formation And Degradation Proteins May Predict Progression Of Multiple Myeloma And Myeloma-Related Bone Disease
- Beacon NewsFlashes – February 5, 2010
- Addition Of Defibrotide To Melphalan-Prednisone-Thalidomide Combination Produces Fewer Side Effects In Multiple Myeloma Patients
- Velcade-Doxil-Dexamethasone Regimen Followed By Post-Transplant Revlimid May Be A Highly Effective Treatment For Newly Diagnosed Myeloma Patients
- Personal Perspective: Former Football Star And Young Father “Dominates” Cancer With Optimism, Information, And Support
- ► January (17)
- Beacon NewsFlashes – January 29, 2009
- Post-Transplant Revlimid Therapy Increases Complete Response Rates In Multiple Myeloma Patients, Study Finds (ASH 2009)
- Despite Side Effects, High-Dose Melphalan Remains The Most Effective Dosage In Preparation For Stem Cell Transplantation
- Velcade Induction and Maintenance Combinations Are Highly Effective In Elderly Multiple Myeloma Patients, Study Finds (ASH 2009)
- Beacon NewsFlashes - January 25, 2010
- Thought Leader Perspective: Dr. Robert Kyle On Myeloma Treatments Requiring Further Study
- Statins Reduce Acute Graft-Versus-Host Disease In Allogeneic Stem Cell Transplants, Study Finds
- Study Compares Out-Of-Pocket Expenses For Myeloma Patients Treated With Velcade, Revlimid, Or Thalidomide (ASH 2009)
- Beacon NewsFlashes – January 14, 2010
- Thought Leader Perspective: Dr. Robert Kyle On Treating Multiple Myeloma
- Celgene Plans To Seek Approval Of Revlimid As An Initial Treatment For Multiple Myeloma
- M-CSF May Act As Powerful Prognostic Factor For Multiple Myeloma
- Papayas, Papain and Multiple Myeloma: A Potential Adjunct Therapy That Requires Further Evaluation
- FDA Approves Velcade’s Data Showing Survival Benefit In Newly Diagnosed Myeloma Patients
- Revlimid May Be More Effective Than Thalidomide In Newly Diagnosed Multiple Myeloma
- Elotuzumab In Combination With Revlimid And Dexamethasone Shows Encouraging Results In Multiple Myeloma (ASH 2009)
- Multiple Myeloma Patients On Thalidomide At Risk For Infection Despite Preventative Medication (ASH 2009)
- ▼ March (7)
- ►2009 (269)
- ► December (17)
- Velcade-Thalidomide-Dexamethasone Treatment Is Promising For Newly Diagnosed Multiple Myeloma (ASH 2009)
- Addition Of Thalidomide To Induction Therapy Increases Response Rates In Younger And Older Multiple Myeloma Patients (ASH 2009)
- NPI-0052 Shows Promise In Relapsed/Refractory Multiple Myeloma (ASH 2009)
- Novel Therapeutic Agents May Reduce Kidney Impairment In Newly Diagnosed Myeloma Patients (ASH 2009)
- Preemptive Treatment Benefits High-Risk Smoldering Myeloma Patients, Study Finds (ASH 2009)
- Revlimid Maintenance Therapy Significantly Extends Disease-Free Survival
- Zolinza Combination Treatments Offer Benefit For Multiple Myeloma Patients (ASH 2009)
- Perifosine Combination Therapy Is Promising For Relapsed And Refractory Multiple Myeloma (ASH 2009)
- Revlimid May Set “New Standard” For Treating Newly Diagnosed Multiple Myeloma In Elderly Patients (ASH 2009)
- Tanespimycin-Velcade Combination Proves Highly Effective In Multiple Myeloma Patients (ASH 2009)
- Survival Greater Than 10 Years In Multiple Myeloma Is Related To Longer Treatment Duration (ASH 2009)
- Beacon NewsFlashes - December 8, 2009
- Velcade-Dexamethasone Combination Regimen Increases Survival In Newly Diagnosed High Risk Myeloma Patients (ASH 2009)
- Carfilzomib Is Effective For Multiple Myeloma – Part 2: Treatment Of Specific Patient Groups (ASH 2009)
- Carfilzomib Is Effective For Multiple Myeloma – Part 1: As A Single Agent Or In A Combination Therapy (ASH 2009)
- Beacon NewsFlashes - December 3, 2009
- Velcade-Melphalan-Prednisone-Thalidomide (VMPT) Treatment Is Highly Active In Elderly Myeloma Patients (ASH 2009)
- ► November (15)
- Velcade-Torisel Combination Proves Highly Effective In Multiple Myeloma Patients (ASH 2009)
- Serum Albumin Levels Indicate Severity Of Multiple Myeloma
- New Velcade Combination Therapy Effective For Newly Diagnosed Myeloma Patients (ASH 2009)
- Treatment Trends For Multiple Myeloma – Part 3: Options For Elderly Multiple Myeloma Patients
- Single-Agent Actimid And Combination Actimid-Dexamethasone Regimens Are Promising Treatments For Relapsed Myeloma (ASH 2009)
- Beacon NewsFlashes – November 23, 2009
- Torisel Achieves Little Response In Relapsed Multiple Myeloma Patients
- Myeloma Research To Be Presented At The American Society of Hematology’s 51st Annual Meeting (ASH 2009)
- Vitamin C Inhibits Anti-Myeloma Activity Of Velcade
- Beacon NewsFlashes – November 13, 2009
- Treatment Trends For Multiple Myeloma – Part 2: Allogeneic Stem Cell Transplants
- The H1N1 Swine Flu Vaccine And Multiple Myeloma: A Comprehensive Review
- Beacon NewsFlashes – November 6, 2009
- Lawsuit Filed To Overturn Ban On Payment For Bone Marrow Donations
- Treatment Trends For Multiple Myeloma – Part 1: Autologous Stem Cell Transplants
- ► October (19)
- Beacon NewsFlashes – October 30, 2009
- Velcade-Doxil-Dexamethasone Combination Treatment Is Highly Effective In Newly Diagnosed Multiple Myeloma Patients
- Thalidomide Improves Outcome Of Double Stem Cell Transplants In Younger Myeloma Patients
- Study Shows Higher Survival With Revlimid And Low-Dose Dexamethasone Than Revlimid And High-Dose Dexamethasone In Multiple Myeloma Patients
- Retreatment With Velcade As A Treatment Option For Relapsed Myeloma Patients
- Phase 2 Clinical Trial Offers Positive Results For A Steroid-Free Multiple Myeloma Treatment
- Beacon NewsFlashes – October 23, 2009
- Study Shows Benefits Of Vesselplasty In The Treatment Of Spinal Fractures
- New Recommendations Issued On Stem Cell Collection And Treatment With Revlimid, Thalidomide, And Velcade
- Multiple Myeloma Study Finds “Complete Response” Is Generally Correlated With Survival
- Myeloma Patients Are At Increased Risk For Blood Clots, Particularly Patients Using Revlimid Or Thalidomide
- Beacon NewFlashes - October 15, 2009
- Onyx Pharmaceuticals To Acquire Proteolix, Developer Of Carfilzomib
- New Directory Could Assist In Myeloma Treatment
- Beacon NewsFlashes – October 8, 2009
- Carfilzomib Is Highly Active In Relapsed Myeloma Patients
- Immune System Cells Protect Myeloma Cancer Cells, Study Finds
- TIMP-1 Biomarker Predicts Myeloma Progression And Survival
- Beacon NewsFlashes – October 2, 2009
- ► September (19)
- Taking Vitamin D And Calcium Supplements Together May Prevent Cancer
- New Drug Enters Phase 2 Clinical Trial For Stem Cell Collection For Blood Cancer Patients
- Second Dose Of Aloxi Further Reduces Chemotherapy-Induced Nausea In Cancer Patients
- New Study Highlights Myeloma Treatment Infection Risks
- Beacon NewsFlashes – September 23, 2009
- Study On Myeloma Diagnosis Techniques Favors Newer Imaging Methods
- Phase 3 Trial Indicates Denosumab Delays Skeletal Related Events In Cancer Patients
- Study Shows Mozobil Induces Mobilization Of Stem Cells But Not Myeloma Tumor Cells
- Study Supports Use Of Kyphoplasty For Multiple Myeloma Patients
- Beacon NewsFlashes – September 16, 2009
- Swine Flu Vaccinations Recommended For Multiple Myeloma Patients
- Beacon NewsFlashes – September 12, 2009
- Red Wine, Resveratrol, And Multiple Myeloma: The Evidence Is Promising, But Needs Further Study
- Multiple Myeloma Conferences To Be Held In Hawaii, Arizona, Canada, And Greece
- FDA To Review Velcade-Melphalan-Prednisone Regimen
- Combination Actimid And Dexamethasone Regimen Is Promising For Relapsed And Refractory Myeloma Patients
- Scientists Find A Protein That Causes Resistance To Velcade Treatment
- Macrophages May Contribute To Survival Of Multiple Myeloma Cells
- Beacon NewsFlashes – September 1, 2009
- ► August (17)
- Personal Perspective: Engineer With Myeloma Finds Hope Through Cancer Support Group And Blogs
- Beacon NewsFlashes – August 27, 2009
- Pathologic Fractures In Bisphosphonate-Treated Patients Not Indicative Of Myeloma Progression
- Personal Perspective: The Adventures Of Cancer Girl
- Eradicating H. pylori Infection Not Linked To MGUS Regression
- Beacon NewsFlashes – August 20, 2009
- Phase 1 Clinical Trial Studies Velcade And Zolinza In Myeloma Patients
- Kidney Failure In Multiple Myeloma Patients - Part 4: Hemodialysis
- Beacon NewsFlashes - August 14, 2009
- Skipped Bone Marrow Exams Give False Positives In Multiple Myeloma Clinical Trials
- Multiple Myeloma Vaccine Shows Promise In Mice
- High Incidence Of Multiple Myeloma In World Trade Center Responders
- Research Shows Velcade’s Possible Mechanism of Action
- Shortage of Clinical Trial Participants Hinders War On Cancer
- Beacon NewsFlashes – August 6, 2009
- Perifosine Advances To Phase 3 Multiple Myeloma Clinical Trial
- Beacon NewsFlashes - August 3, 2009
- ► July (20)
- Study Shows Toxicity Of Second Transplant For Myeloma Patients
- Clinical Trials Start For A Pre-Transplant Treatment
- Researchers Sequence Full Multiple Myeloma Tumor Genome
- Beacon NewsFlashes – July 28, 2009
- Multiple Myeloma Patients’ Relatives Are Twice As Likely To Have MGUS
- Dr. Sagar Lonial Provides Insight Into High-Risk Myeloma
- Vitamin D Deficiency May Cause Skeletal Complications In Multiple Myeloma Patients
- Clinical Trial Supports Revlimid As First-Line Therapy For Myeloma
- Anti-DKK1 Antibody As New Treatment For Myeloma Bone Disease
- Beacon BreakingNews - Clinical Trial Supports Revlimid As First-Line Therapy For Myeloma
- Beacon NewsFlashes – July 21, 2009
- Kidney Failure In Multiple Myeloma Patients – Part 3: Time and Care Commitments
- Dental Exams Recommended Before Bisphosphonate Therapy
- Kidney Failure In Multiple Myeloma Patients - Part 2: Treatment
- Beacon NewsFlashes -- July 14, 2009
- Quality Of Life Warrants More Consideration In Multiple Myeloma Treatment Recommendations
- Study Examines Quality Of Life After Stem Cell Transplantation
- Beacon NewsFlashes – July 8, 2009
- Vegetarians Less Likely To Develop Multiple Myeloma
- Revlimid As Initial Myeloma Therapy Inhibits Stem Cell Collection
- ► June (17)
- Beacon NewsFlashes — June 30, 2009
- Kidney Failure In Multiple Myeloma Patients - Part 1: Overview
- XRCC5 Gene Variants Associated With Greater Blood Clot Risk During Thalidomide Treatment
- Stem Cell Transplants May Improve Kidney Function of Myeloma Patients
- Beacon NewsFlashes -- June 24, 2009
- U.K. Finalizes Revlimid Therapy Guidelines
- Canadian Authorities Confiscating Thalidomide At Border
- Velcade Plus Dexamethasone Produces Robust, Yet Short-Lived, Response In Myeloma Patients
- Beacon NewsFlashes - June 15, 2009
- Revlimid Boosts Immune System Of Some Myeloma Patients
- Beacon NewsFlashes - June 9, 2009
- Study Shows Acute Kidney Failure Can Be Reversed By Velcade-Dexamethasone-Doxorubicin In Multiple Myeloma
- Total Therapy Emerges As Prospect For Multiple Myeloma Cure
- Myeloma Precursor MGUS Linked To Pesticide Use
- Beacon NewsFlashes – June 3, 2009
- Expert Panel Recommends European Approval Of Mozobil
- Study Examines Romidepsin-Velcade Combination Treatment In Myeloma Patients (ASCO 2009)
- ► May (23)
- ONJ As A Prognostic Factor In Myeloma Patients Treated With Zometa (ASCO 2009)
- Beacon NewsFlashes - May 29, 2009
- Nexavar Shows No Effect In Phase 2 Study (ASCO 2009)
- MMRF Announces Research Collaboration With The Broad Institute
- Clinical Trial Shows Ginger Reduces Nausea (ASCO 2009)
- New Hemodialysis Procedure Improves Health Of Multiple Myeloma Patients
- IGF-1: An Important Myeloma Growth Factor
- Trial Investigates Effects Of Tanespimycin-Velcade Combination Treatment (ASCO 2009)
- Autologous Stem Cell Transplant Therapy With Velcade-Revlimid Or Velcade-Thalomid in New Multiple Myeloma Patients (ASCO 2009)
- Phase 3 Study Shows High Response Rates For Four-Drug Combination (ASCO 2009)
- Beacon NewsFlashes - May 18, 2009
- Formaldehyde Exposure Linked To Increased Risk Of Multiple Myeloma
- ASCO 2009 - 45th Meeting Of The American Society Of Clinical Oncology Only Two Weeks Away
- Myeloma Patients In Canada Smuggle Low-Priced Thalidomide
- Beacon NewsFlashes – May 13, 2009
- Mozobil With Neupogen Increases Stem Cell Harvest Efficiency
- Iowa Firefighters And Police Officers To Benefit From Cancer Bill
- Durie-Salmon Staging System And International Staging System Compared In Patients After ASCT
- Socioeconomic Standing May Affect Survival For Swedish Myeloma Patients
- Beacon NewsFlashes – May 9, 2009
- Current Use Of Velcade In Newly Diagnosed Myeloma Patients
- Study Projects Rising Cancer Rates In The United States
- New Hampshire Legislature Approves Medical Marijuana Bill
- ► April (29)
- Study Finds Lack Of Evidence For Link Between Firefighting And Cancer
- Beacon NewsFlashes — April 28, 2009
- The Access To Cancer Trials Act Of 2009 Brought Before Congress
- Beacon NewsFlashes — April 27, 2009
- NICE Recommends Revlimid For Multiple Myeloma Patients In U.K.
- Melphalan-Prednisone Survival Rates Higher Than Thalidomide-Dexamethasone In Elderly
- Study Measures Effects Of Novel Drugs On Myeloma Patients With Chromosomal Abnormalities
- Beacon NewsFlashes – April 22, 2009
- Long-Term Outcome Of Combination Auto/Allo Stem Cell Transplant Treatment Reported
- Beacon NewsFlashes – April 20, 2009
- Beacon NewsFlashes – April 17, 2009
- New Revlimid Warning For Patients With Impaired Kidney Function
- Gene Identification Could Lead To Better Treatment Options For Multiple Myeloma
- High-Risk Myeloma Patients Show Overall Lower Progression-Free Survival With Revlimid-Dexamethosone Therapy
- Thalidomide Plus Prednisone Shown To Improve Survival After ASCT
- Beacon NewsFlashes – April 13, 2009
- Beacon NewsFlashes – April 10, 2009
- IMW 2009 - Physicians Debate "Cure Versus Control" Of Myeloma
- IMW 2009 – Physicians Discuss Induction Therapy For Non-Transplant Candidates
- IMW 2009 - Elotuzumab And Panobinostat Clinical Trials With Velcade
- CMS Decides To Cover PET Scans For Myeloma Patients
- Addition Of Second Drug Could Dramatically Improve Velcade Response
- Beacon NewsFlashes – April 7, 2009
- Tools For Diagnosing Multiple Myeloma / Part 4: Specialized Studies
- Growth In Off-Label Drug Use Slows
- Blood Cancers Forum Focuses On Importance Of Clinical Trials
- IMW 2009 – Physicians Discuss Upfront And Induction Therapy For Transplant Candidates
- Beacon NewsFlashes – April 1, 2009
- Medicare Expands Coverage Of Off-Label Uses Of Cancer Drugs – Part 2: Medicare-Approved Compendia
- ► March (31)
- New Gene Implicated In Multiple Myeloma And Other Cancers
- Kennedy Renews War On Cancer
- The MMRF Marathon And Half Marathon Program Seeks Runners
- Beacon NewsFlashes – March 29, 2008
- Beacon NewsFlashes - March 27, 2009
- Genetic Blood Tests Could Soon Identify Multiple Myeloma And Other Disorders
- Beacon NewsFlashes – March 25, 2009
- Tools For Diagnosing Multiple Myeloma / Part 3: Prognostic Evaluation
- Beacon NewsFlashes – March 23, 2009
- Beacon NewsFlashes – March 21, 2009
- Beacon NewsFlashes – March 20, 2009
- Scotland Expected To Improve Patient Access To New Cancer Therapies
- Beacon NewsFlashes - March 16, 2009
- IMW 2009 - Physicians Discuss New Drugs For Relapsed/Refractory Patients
- Beacon NewsFlashes - March 14, 2009
- Tools For Diagnosing Multiple Myeloma / Part 2: End-Organ Damage Evaluation
- New Myeloma Drugs Target Different Mechanisms: Misfolded Proteins
- Current Information On Response Criteria For Multiple Myeloma
- IMW 2009 - Physicians Discuss Symptom Management Strategies
- Beacon NewsFlashes - March 10, 2009
- Managing The Side Effects Of Revlimid And Velcade
- Beacon NewsFlashes – March 9, 2009
- Current Information On Risk Stratification In Multiple Myeloma
- New Myeloma Drugs Target Different Mechanisms: Signaling Pathways
- Beacon NewsFlashes - March 6, 2009
- IMW 2009 - Waldenstrom's Award Goes To IMF Co-Founder And Chairman
- Blood Disorder MGUS Precedes Most Cases Of Multiple Myeloma
- The MMRF Awards $1 Million For Promising Early-Stage Drug Development
- Beacon NewsFlashes – March 2, 2009
- IMW 2009 – Consensus On Risk Stratification In Multiple Myeloma
- Beacon NewsFlashes - March 1, 2009
- ► February (32)
- Current Information On Staging Multiple Myeloma
- New Myeloma Drugs Target Different Mechanisms Of Action: Cell Surface Receptors
- Canadian Survey Highlights Myeloma Awareness And Access To Treatment
- Beacon NewsFlashes - February 24, 2009
- IMW 2009 - Physicians Offer Standardized Guidelines For Diagnosing Suspected Multiple Myeloma
- Radiation Not Linked To MGUS Progression To Multiple Myeloma
- Beacon NewsFlashes - February 23, 2009
- IMW 2009 - Doctors Clarify Standards For Clinical Trial Reporting
- Physicians Perform First Bone Marrow Transplant At Public Hospital In West Bengal, India
- Health Care-Associated MRSA In Decline
- XII International Myeloma Workshop Begins Next Week
- Clarifications And Updates In Diagnosis Criteria Of Multiple Myeloma
- Tools For Diagnosing Multiple Myeloma / Part 1: Diagnostic Evaluation
- Beacon NewsFlashes - February 18, 2009
- Bill Helps Oregon Firefighters Get Cancer Coverage
- Medicare Expands Coverage Of Off-Label Uses Of Cancer Drugs – Part 1
- MMRF And LLS Grant $500,000 For Study Of The Multiple Myeloma Stem Cell
- The American Society Of Clinical Oncology Provides A Financial Guide To Cancer Care
- Long-Term Survival Estimates Increase For Young Multiple Myeloma Patients
- Researchers Identify Novel Tumor Feeding Mechanism
- Beacon NewsFlashes - February 11, 2009
- Beacon NewsFlashes - February 11, 2009
- Leukemia & Lymphoma Society And Women’s Running Magazine Join Forces To Launch New Women’s Half Marathon
- Regulations And The Rising Cost Of Cancer Drugs
- MMRF Is The Official Charity Of The Rite Aid Cleveland 5K
- Beacon NewsFlashes - February 6, 2009
- Green Tea Blocks Effectiveness Of Velcade Treatment
- Beacon NewsFlashes - February 4, 2009
- Study Finds No Link Between Hair Dyes And Myeloma
- Beacon NewsFlashes – February 2, 2009
- Deal Brings Revlimid To U.K. Myeloma Patients
- Beacon NewsFlashes - February 1, 2009
- ► January (30)
- Preventive Measures Can Reduce Osteonecrosis Of The Jaw In Patients Taking Zometa
- Fruits And Vegetables Do Not Decrease Risk of Multiple Myeloma
- Beacon NewsFlashes – January 28, 2008
- FJC Awards $1 Million Grant To Institute For Myeloma And Bone Cancer Research
- Blood Cancers The Subject Of Seminar At University Of Chicago Medical Center
- Beacon NewsFlashes – January 26, 2009
- Radiation Therapy, Vertebroplasty, And Kyphoplasty: Three Treatments For Myeloma Bone Disease
- Scientists Develop Serum Immunoglobulin Free Light Chain Assay For Early Myeloma Diagnosis
- Chemical Used In Rubber Synthesis Increases Risk Of Myeloma
- New Drug for Preventing Nausea and Vomiting During Chemotherapy
- Beacon NewsFlashes – January 21, 2009
- MMRF Meeting Discusses Prognosis And Treatments For Myeloma Patients
- Multiple Myeloma Treatment Approaches And Objectives
- Phase 3 Zolinza-Velcade Trial Opening Soon
- New Clinical Trials Combine Zolinza And Velcade For Multiple Myeloma Treatment
- Beacon NewsFlashes - January 19, 2009
- Thalomide Approved For First-Line Treatments In Scotland
- Treatment In Elderly Multiple Myeloma Patients
- Tandem Autologous Stem Cell Transplantation Compared To Single Autologous Stem Cell Transplantation
- Managing Steroid-Related Side Effects In Myeloma Patients
- MMRF Meeting Discusses Racial Disparities In Multiple Myeloma
- Novel Therapies For Myeloma Bone Disease
- Beacon NewsFlashes – January 13, 2009
- Bisphosphonate Treatment For Myeloma Bone Disease
- Beacon NewsFlashes – January 9, 2009
- Phase 1 Clinical Trial Of CX-4945 Begins In Cancer Patients
- U.K. To Expand Access To Drugs For Terminally Sick
- Anti-Cancer Drug Zolinza Shows Potential In Myeloma
- Beacon NewsFlashes – January 5, 2009
- Osteoporosis Drug Increases Risk Of Esophageal Cancer And Jaw Disease
- ► December (17)
- ►2008 (65)
- ► December (34)
- Beacon NewsFlashes - December 30, 2008
- Cancer Drugs To Cost More Under Medicare Plans
- Leading Oncologists Present Clinical Research Advances in 2008
- Clinical Trials Begin For New Form Of Radiotherapy
- Skeletal Imaging For Bone Lesions In Multiple Myeloma Patients
- ASH 2008 - New Induction Therapy for Elderly Patients
- ASH 2008 - High Response Rate for Revlimid-Velcade-Dexamethasone Treatment in Phase 2 Studies
- Diana Krall To Host Fundraiser Benefiting Blood Cancer Patients
- FDA Approves Mozobil For Myeloma Patients Preparing For Stem Cell Transplants
- Treatment In Young Multiple Myeloma Patients
- ASH 2008 – Results Of Tandem Stem Cell Treatment For Newly Diagnosed Myeloma Patients
- ASH 2008 - Ongoing Phase 2 Clinical Trials For Carfilzomib Show Promising Results
- ASH 2008 - Carfilzomib, A Novel Drug Related To Velcade, Reduces Peripheral Neuropathy
- ASH 2008 – Trial Results Compare Multiple Myeloma Transplantation Procedures
- ASH 2008 – Venous Thrombotic Events In Newly Diagnosed Myeloma Patients Decrease Overall Survival
- Beacon NewsFlashes - December 16, 2008
- Impact of PET Scans Consistent Across All Types of Cancer
- ASH 2008 – Perifosine Effective Against Multiple Myeloma In Combination With Dexamethasone-Revlimid And Dexamethasone-Velcade
- Beacon NewsFlashes - December 12, 2008
- ASH 2008 – Clinical Trial Update for Velcade-Thalidomide-Dexamethasone With Autologous Stem Cell Transplantation In Newly Diagnosed Myeloma Patients
- Multiple Myeloma Research Consortium Announces Center Of The Year
- ASH 2008 – Updated Velcade-Melphalan-Prednisone Trial Results For Newly Diagnosed Myeloma Patients
- Deep Vein Thrombosis Risk Higher In Multiple Myeloma
- ASH 2008 - VDD Initial Treatment More Effective Than TD Initial Treatment
- ASH 2008 - Actimid-Dexamethasone Combination Highly Effective In Treating Relapsed And Refractory Multiple Myeloma
- ASH 2008 - Scientists Reveal Promising Four-Drug Regimen For Newly-Diagnosed Myeloma Patients
- Phase 3 Trials Of Hsp90 Inhibitors In Cancer Patients Underway
- Outpatient Stem Cell Transplant For Multiple Myeloma
- New Therapies Show Promise For Multiple Myeloma Treatment
- Beacon NewsFlashes - December 5, 2008
- Multiple Myeloma Survivors Honored At 2008 ASH Meeting
- 50th Annual Meeting Of The American Society Of Hematology Only Days Away
- Beacon NewsFlashes – December 2, 2008
- Physicians Discuss Past Progress And Future Goals In Treating Multiple Myeloma
- ► November (30)
- Holiday Party In Las Vegas To Benefit The Leukemia & Lymphoma Society
- Parade In New Zealand To Benefit Families Living With Multiple Myeloma
- U.S. Cancer Incidence And Mortality Rates Fall For The First Time
- Revlimid Combination Effective Against Relapsed And Refractory Myeloma
- Beacon NewsFlashes - November 23, 2008
- Increased Risk Of Blood Clotting Reported In Patients Treated With Avastin
- IMF Continues Support Of Peter Boyle Memorial Fund
- Long-Term Exposure To Benzene Appears To Increase Risk Of Multiple Myeloma
- New Technique Shows Improved Detection Of Myeloma Tumor Cells After Treatment
- IMF Announces New Global Research Partnership To Study Multiple Myeloma Biomarkers
- Beacon NewsFlashes - November 17, 2008
- Treatment With Folic Acid And B Vitamins Has Little Effect On Multiple Myeloma Risk Among Women
- Beacon NewsFlashes - November 14, 2008
- Link Between Gene Variation And Myeloma Survival
- ImmunoCellular Therapeutics Presents Data Showing Immune Response On Cancer Stem Cells
- Occupation And Chemical Exposure Linked To Multiple Myeloma
- African-Americans Still At Higher Risk Of Developing Multiple Myeloma
- Beacon NewsFlashes - November 11, 2008
- CIGNA, Leukemia & Lymphoma Society Promote Financial Aid Program
- Beacon NewsFlashes - November 7, 2008
- International Myeloma Foundation Calls For Patient Access To Newest Myeloma Treatments
- Beacon NewsFlashes – November 6, 2008
- Antibody Treatment In Mice Shows Antitumor Activity
- Prolexys Pharmaceuticals Raises $20 Million to Further Work on Anti-tumor Molecule
- Immune System Cells Show Promise As Myeloma Therapy
- FDA Approves Cephalon's Treanda for Second Cancer Indication
- MMRF Raises Over $1.5 Million In Annual Fall Gala
- Incidence Of Multiple Myeloma In Women May Correlate With Height, Not Obesity
- England And Wales May Halt Funding For Revlimid
- Scientist Receives $720,000 Grant To Research New Myeloma Drug Targets
- ► October (1)
- ► December (34)
Leave a comment